−4.0632PLN
−92.11 MPLN
46.86 MPLN
15.37 M
About RYVU
Sector
CEO
Pawel Przewiezlikowski
Headquarters
Kraków
Website
Employees (FY)
276
Founded
2007
ISIN
PLSELVT00013
FIGI
BBG00JHW7QN9
Ryvu Therapeutics SA engages in the provision of products and solutions for the pharmaceutical and biotechnology industry. Its projects and services include contract chemistry services, biology services, integrated drug discovery, and comparative studies of biosimilar medicinal products. The company was founded by Boguslaw Sieczkowski and Pawel Przewiezlikowski in 2007 and is headquartered in Krakow, Poland.
An aggregate view of professional's ratings.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 0RKT is 39.3970 PLN — it hasn't changed in the past 24 hours. Watch RYVU THERAPEUTICS SA PLN0.40 stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on LSE exchange RYVU THERAPEUTICS SA PLN0.40 stocks are traded under the ticker 0RKT.
We've gathered analysts' opinions on RYVU THERAPEUTICS SA PLN0.40 future price: according to them, 0RKT price has a max estimate of 80.00 PLN and a min estimate of 64.00 PLN. Watch 0RKT chart and read a more detailed RYVU THERAPEUTICS SA PLN0.40 stock forecast: see what analysts think of RYVU THERAPEUTICS SA PLN0.40 and suggest that you do with its stocks.
0RKT reached its all-time high on Feb 20, 2018 with the price of 44.4426 PLN, and its all-time low was 36.9779 PLN and was reached on Dec 14, 2017. View more price dynamics on 0RKT chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
0RKT stock is 0% volatile and has beta coefficient of 0.07. Track RYVU THERAPEUTICS SA PLN0.40 stock price on the chart and check out the list of the most volatile stocks — is RYVU THERAPEUTICS SA PLN0.40 there?
Today RYVU THERAPEUTICS SA PLN0.40 has the market capitalization of 1.16 B, it has increased by 1.24% over the last week.
Yes, you can track RYVU THERAPEUTICS SA PLN0.40 financials in yearly and quarterly reports right on TradingView.
0RKT net income for the last quarter is −19.40 M PLN, while the quarter before that showed −27.75 M PLN of net income which accounts for 30.10% change. Track more RYVU THERAPEUTICS SA PLN0.40 financial stats to get the full picture.
No, 0RKT doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Jun 28, 2024, the company has 276.00 employees. See our rating of the largest employees — is RYVU THERAPEUTICS SA PLN0.40 on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. RYVU THERAPEUTICS SA PLN0.40 EBITDA is −110.57 M PLN, and current EBITDA margin is −228.79%. See more stats in RYVU THERAPEUTICS SA PLN0.40 financial statements.
Like other stocks, 0RKT shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade RYVU THERAPEUTICS SA PLN0.40 stock right from TradingView charts — choose your broker and connect to your account.